MediKane Holdings Limited ("MediKane") has today released an IM designed to provide an opportunity for existing shareholders and new investors to take up shares in MediKane. The funds raised will be applied to increase sales of existing products, invest in new products and aid expansion, particularly into the USA. MediKane treats chronic conditions with disruptive plant-based Food-as-Medicine products. The Company reserves the right to close the Offer at its discretion.

lodged with ASX 11 Oct 2021

Annual Report lodged 30 Sept 2021

App 4G lodged 30 Sept 2021

corrects an earlier 3Y

ASW lodges with ASX today its Preliminary Final Report

ASW will pay a dividend of 2c (fully franked at 25%) per ordinary share. Also, given the Company’s strong performance for FY21 it will also pay a special dividend of 1c (fully franked at 25%) per ordinary share in addition to the ordinary dividend noted above. Accordingly, the total of the ordinary and special dividends to be paid is 3c (fully franked at 25%) per share.